2,2,2-TRIFLUORO-1-(1,2,4,5-TETRAHYDRO-6,8-DIAMINO-1,5-METHANO-3H-3-BENZAZEPIN-3-YL)ETHANONE
UNII NMD2MGF6S3
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,2,2-trifluoro-1-(1,2,4,5-tetrahydro-6,8-diamino-1,5-methano-3h-3-benzazepin-3-yl)ethanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NMD2MGF6S3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H14F3N3O TXNXRXAEOOBQGX-RQJHMYQMSA-N;TXNXRXAEOOBQGX-NKWVEPMBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,2,2-trifluoro-1-(1,2,4,5-tetrahydro-6,8-diamino-1,5-methano-3h-3-benzazepin-3-yl)ethanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.